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Abstract 
The ductus venosus (DV) is a vascular shunt situated within the fetal liver 
parenchyma connecting the umbilical vein to the inferior vena cava. This vessel acts 
as a bypass of the liver microcirculation and plays a critical role in the fetal 
circulation. The DV allows oxygenated and nutrient-rich venous blood to flow from 
the placenta to the myocardium and brain. Increased impedance to flow in the fetal 
DV is associated with fetal aneuploidies, cardiac defects and other adverse pregnancy 
outcomes. This review serves to improve our understanding of the mechanisms that 
regulate the blood flow redistribution between the fetal liver circulation and fetal heart 
and the clinical significance of the DV waveform as generated by pressure-volume 
changes in the fetal heart. 
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Introduction  
The ductus venosus (DV) is a vascular shunt situated within the fetal liver 
parenchyma connecting the umbilical vein (UV) to the inferior vena cava (Figure 1). 
This vessel acts as a bypass of the liver microcirculation and plays a critical role in the 
fetal circulation. The DV allows oxygenated and nutrient-rich venous blood to flow 
from the placenta to the brain and myocardium, projecting a high-velocity jet flow 
posteriorly, from the umbilical vein to the foramen ovale [1]. The blood distribution 
through the DV is related to changes in umbilical venous pressure, blood viscosity, 
and an active regulation of the diameter of the entire DV [2]. Anatomically, the DV 
and the intrahepatic branches of the portal vein are arranged in parallel [3]. During 
pregnancy, the mean fraction of blood shunted through the ductus is not a constant 
[2,3]. In human fetuses, the DV shunting rate is approximately 20-30%, and increases 
in the DV shunting rate are a general adaptational mechanism to fetal distress [3] 
during extreme challenges of placental compromise or hypoxemia [2,4,5]. 
Additionally, the DV acts as a transmission line to the umbilical vein from pulse 
waves generated in the heart [2]. These waves, which may reflect cardiac function, are 
substantially influenced by the local variation of impedance and compliance [1]. 
An increased pulsatility index or impedance to flow in the fetal DV is associated with 
fetal aneuploidies, cardiac defects and other adverse pregnancy outcomes [6,7-9]. 
This review serves to improve our understanding of the mechanisms that regulate the 
blood flow redistribution between the fetal liver circulation and the DV and to analyze 
the clinical significance of the DV waveform as generated by pressure-volume 
changes in the fetal heart. 
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Figure 1. Anatomy of the ductus venosus (DV). The DV is a vascular shunt situated 
within the fetal liver parenchyma connecting the umbilical vein (UV) to the inferior 
vena cava and right atrium (RA). 
 
Methods 
To compose this review, a thorough literature search was repeatedly performed in 
PubMed and Medline, with a limitation for articles written in the English language. 
Search terms used were DV, fetal venous circulation, DV shunting, ultrasound, and 
Doppler velocimetry. 
  
Ductus venosus development and anatomy 
The arteries and veins are developed by a combination of vasculogenesis and 
angiogenesis [10]. This process involves a series of steps. Vasculogenesis (VS) is the 
process of blood vessel formation occurring by de novo production of endothelial 
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cells and the construction of the primitive vascular plexus inside the embryo. 
Sometimes VS is treated as synonymous with angiogenesis, which is responsible for 
the remodeling and expansion of this network. VS is under the control of signaling 
molecules secreted from endoderm cells and begins first in the yolk sac at day 17, 
where Indian hedgehog, bone morphogenic protein, and transforming growth factor β 
(TGF-β) modulate the yolk sac's mesoderm to originate hemangioblastic aggregates 
[11]. These cellular hemangioblastic aggregates are composed for hematopoietic stem 
cells and endothelial cells that coalesce to form the extraembryonic umbilical vessels 
to act as a circulatory connection between the embryo and the maternal 
compartments. Much of this complex vascular network development is under the 
influence of vascular endothelial growth factor (VEGF) [10-13]. In addition, 
angiogenesis remodels this vascular system, promoting vascular intussusception that 
is facilitated by hypoxia. Oxygen depletion activates the expression of several genes, 
including those encoding VEGF, angiopoietin-2, and nitric oxide synthase [11]. These 
proteins are important modulators of cell proliferation induction, guided migration, 
differentiation and cell-to-cell communication [14]. 
 
At 4 weeks of gestation, a group of capillary networks begins to develop into the 
definitive veins of the embryo. At the same time, three paired venous systems form. 
The vitelline veins drain the yolk sac and the developing gastrointestinal tract, the 
umbilical veins return oxygenated blood from the placental tissue, and the cardinal 
veins drain the embryo [11]. Before the vitelline vein enters the venous end of the 
heart (sinus venosus), it forms the hepatic sinusoids in the developing liver [11]. The 
left vitelline vein regresses, and the enlarged right vitelline vein in the liver becomes 
the DV [10,11]. The umbilical vein brings oxygenated blood from the placenta to the 
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heart. Initially, the umbilical veins are paired, but as the embryo develops, the right 
umbilical vein degenerates, whereas the left persists [11]. The left umbilical vein 
forms a direct anastomosis with the DV, which delivers oxygen- and nutrient-rich 
blood from the placenta to the embryo-fetal heart. After birth, under normal 
conditions, the DV regresses and becomes the ligamentum venosum. 
 
Ductus venosus shunting  
The mechanism of redistribution of blood flow between the fetal liver and the DV is 
still a matter of debate [3]. DV shunting corresponds to the percentage of umbilical 
blood flow that enters the DV, which is arranged in parallel to the intrahepatic 
branches of the portal vein [3] (Figure 1). This aspect is of particular relevance 
because the amount of blood that is conducted by the DV is proportional to the 
resistance of the hepatic venous circulation [15,16]. In other words, the flow 
regulation in the DV is a variable dependent on the degree of permissiveness to the 
flow through this blood channel. 
 
DV shunting can be assessed during pregnancy using the indicator dye-dilution 
method, a radioactively labeled microsphere technique, and blood flow volume 
measurement using the Doppler ultrasound technique. In experimental situations in 
which the degree of blood flow through the DV is evaluated, the increase in the DV 
shunting rate is a defense mechanism. Therefore, theoretically, an increased DV/UV 
ratio is a sign of a potential hemodynamic compromise. The proportion of umbilical 
blood shunting through the DV has been evaluated in several animals, such as sheep 
[17-26], macaques [27], baboons [5-28], marmosets [5] and, finally, humans 
[15,16,25,29-32]. 
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Approximately 2 decades ago, Bellotti and colleagues [31] used color Doppler 
sonography to study umbilical, DV, and hepatic flows in 137 normal fetuses between 
20 and 38 weeks of gestation. In all of the venous segments examined, blood flow 
increased significantly with advancing gestational age [31]. The weight-specific 
amniotic umbilical flow did not change significantly during gestation (120 ± 44 ml. 
min-1 kg-1), whereas DV flow decreased significantly (from 60 to 17 ml min-1 kg-1). 
The percentage of umbilical blood flow shunted through the DV decreased 
significantly (from 40% to 15%); consequently, the percentage of flow to the liver 
increased during gestation. The right lobe flow changed from 20 to 45%, whereas the 
left lobe flow was approximately constant (40%) [31]. The authors suggested that 
these changes are related to different patterns of growth of the umbilical veins and DV 
diameters [31], and the findings support the hypothesis that the DV plays a less 
important role in shunting well-oxygenated blood to the brain and myocardium in late 
normal pregnancy than in early gestation, which leads to increased fetal liver 
perfusion [31].  
 
The degree of shunting through the DV in the human fetus seems to be associated 
with fetal growth. In the study of Kiresud and colleagues, the average fraction shunted 
through the DV was 28% to 32% at 18 to 20 weeks, decreased to 22% at 25 weeks, 
and reached 18% at 31 weeks [30]. In this cross-sectional ultrasonographic study, 
fetuses at <10th percentile for birth weight had significantly more shunting (1.4%) 
than those at >90th percentile (95% confidence interval, 0.1%-2.7%; p =0.04) [30]. In 
fact, Doppler velocimetry of the DV is abnormal only when fetuses are severely 
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compromised, whereas the ratio of DV to UV flow rates might be an indicator of 
impaired fetal condition [33]. 
Tchirikov and colleagues have analyzed the blood flow rate through the liver as the 
difference between umbilical venous and DV blood flow [33]. The authors observed 
that the liver blood flow was significantly decreased in pregnancies with intrauterine 
growth retardation compared with normal pregnancies [33], and the normalized liver 
perfusion was significantly decreased only in intrauterine growth retardation 
pregnancies [33]. The relative increase in DV blood flow in intrauterine growth 
retardation was attributed by the authors to an increase in hepatic vascular resistance 
and not to increases in the DV diameter. Later, the same group of authors 
hypothesized that changes in blood content of the liver evoked alterations to the 
vascular geometry of the DV, which would also affect its resistance to flow [33]. As a 
consequence, these results suggest that the main factor responsible for the DV 
shunting regulation is the degree of resistance achieved by the portal circulation, the 
latter acting as a functional modulator of the flow through the DV. 
 
Jensen and colleagues have examined the effect of graded reduction in uterine blood 
flow on distribution of cardiac output and oxygen delivery to fetal organs and venous 
blood flow patterns in 9 fetal sheep using the radionuclide-labeled microsphere 
technique [24]. The results of this experiment described a graded reduction in uterine 
blood flow that induced a redistribution of fetal oxygen delivery and in venous flow 
patterns [24], influencing the DV shunting. Approximately 15 years later, the 
umbilical venous flow, DV blood flow, and blood flow to the fetal liver in 56 severely 
intrauterine growth-restricted fetuses with an abnormal pulsatility index of the 
umbilical artery were compared with 137 normal control fetuses [16]. In severe 
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intrauterine growth-restricted fetuses, Doppler examination of blood flow volume 
showed a significant increase in the shunting of umbilical vein blood flow through the 
DV and noted a relatively constant blood flow to the heart and brain at the expense of 
fetal hepatic perfusion [16]. These observations suggested that chronic hypoxia 
promotes the flow of more oxygenated blood from the DV towards the left heart, 
coronary circulation and fetal brain, which is a much more ancillary effect to achieve 
in acute situations or in cases of severe fetal UV compromise. This reasoning can be 
observed in one experimental study performed in 11 anesthetized pregnant sheep, in 
which the obliteration of one umbilical artery increases the DV/umbilical vein volume 
flow (mL/min/kg) ratio [26]. In addition, compression of the umbilical cord shifts 
down blood flow velocity profiles in the DV, increasing dramatically the pulsatility 
index of this vessel [26]. 
 
To study the regulation of the DV inlet in vivo, Kiresud and colleagues measured the 
effects of vasoactive substances and hypoxemia on its diameter in nine fetal sheep in 
utero at 0.9 gestation under ketamine-diazepam anesthesia [25]. Hypoxemia caused a 
61% increase of the inlet diameter and a distension of the entire DV, suggesting that 
the DV inlet is under active regulation, demonstrated by its distension during infusion 
of an NO donor or hypoxemia [25]. This observation has never been demonstrated in 
humans, and therefore, the presence of a sphincter in the trajectory of the DV remains 
controversial.  
 
Fetal ductus venosus flow assessment in daily clinical practice 
Doppler ultrasound is the technology of current use in daily clinical practice for the 
evaluation of the fetal DV waveform. In the recent years, as a result of the 
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technological evolution in this area, especially in the quality and resolution of the 
ultrasound systems, Doppler ultrasound has proven to be an excellent technology for 
non-invasive evaluation of the fetal circulation. In particular, DV evaluation is a 
technique that requires training and should be used for clinical decisions when it is 
performed by trained and properly certified operators. In fact, competence in Doppler 
assessment of the DV is achieved only after extensive supervised training [34].  
 
 
Figure 2. Color Doppler imaging of the ductus venosus (DV) and a normal first-
trimester DV waveform.  
 
The evaluation of the DV flow can be made in the first [35-40] or second and third 
trimesters of pregnancy [41-49] (Figures 2 and 3). The DV can be visualized in a mid-
sagittal longitudinal plane of the fetal trunk or in an oblique transverse plane through 
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the upper abdomen [50]. According to the Fetal Medicine Foundation protocol [51], 
DV examination should be undertaken during fetal quiescence, in the absence of fetal 
movements. For an adequate observation of the DV, the magnification of the image 
should be such that the fetal thorax and abdomen occupy the whole image, and a right 
ventral mid-sagittal view of the fetal trunk should be obtained [51]. Color flow 
mapping should be undertaken to demonstrate the umbilical vein, DV and fetal heart 
[51]. This protocol suggests that the pulsed Doppler sample volume should be small 
(0.5-1.0 mm in the first trimester and 1.0-2.0 mm in the second and third trimesters) 
to avoid contamination from the adjacent veins, and it should be placed in the 
yellowish aliasing area. The insonation angle should be less than 30 degrees and the 
filter should be set at a low frequency (50-70 Hz) so that the a-wave is not obscured. 
The sweep speed should be high (2-3 cm/s) so that the waveforms are spread, 
allowing better assessment of the a-wave [51]. When these criteria are satisfied, it is 
possible to assess the a-wave and determine qualitatively whether the flow is positive, 
absent or reversed. The DV pulsatility index (DV-PIV), which is the Doppler ratio 
most utilized in daily clinical practice for impedance assessment of the DV, is 
measured by the machine after manual tracing of the outline of the waveform [51]. 
 
It is important to remember that the peak systolic velocity increases from 48 cm/s at 
14 weeks to 71 cm/s at 41 weeks; therefore, the spectrum obtained by Doppler 
ultrasound should be in agreement with previously published reference curves [50,52-
55]. This is particularly relevant because of the similarity between DV waveforms and 
suprahepatic veins, which are in a satellite location to the DV and can be easily 
confused with the DV spectra. The DV exhibits a normal flow-velocity profile that is 
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typically antegrade throughout the entire cardiac cycle [56]. This feature is permissive 
to the semi-quantitative evaluation of its complex waveform. 
 
 
Figure 3. Color Doppler imaging of the ductus venosus (DV) and a normal second-
trimester DV waveform. 
 
The denomination of the phases that make up the DV venous flow-velocity waveform 
is closely related to the respective period of the cardiac cycle. In normal conditions, 
the cardiac cycle involves five distinct phases: early diastole, atrial contraction, 
isovolumetric contraction, ejection phase, and isovolumetric relaxation.  
During the isovolumetric contraction phase of the cardiac cycle, the ventricular 
pressure rises steeply with no change in ventricular volume as both the 
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atrioventricular and semilunar valves are closed [57]. As the ventricular pressure 
continues to rise, it exceeds the pressure within the great arteries, and the semilunar 
valves open, resulting in rapid ejection of blood [57]. With ventricular ejection, 
myocardial deformation ensues, and this phase is associated with a drop in ventricular 
volume and pressure [57]. With the initiation of ventricular systole, the descent of the 
atrioventricular valve ring decreases atrial pressure and increases the amount of 
venous return that can be accommodated by the atria [56]. This produces the first 
increase in venous forward velocities, which peak at the S-wave [56] (Figure 2/3). As 
the ventricular pressure drops below the pressure within the great arteries, the 
semilunar valves close [57]. A period of isovolumetric relaxation ensues, which is 
associated with decreased ventricular pressure with no change in ventricular volume 
as the atrioventricular valves are closed [57]. At this time, the AV valve ring ascends 
towards its resting position, atrial pressures rise, and venous forward velocities fall to 
the first trough, designated the v-descent. As the ventricular pressure decreases below 
that of the atria, the atrioventricular valves open [57], and the higher pressures in the 
atria lead to an opening of the AV valves, allowing for an increase in venous forward 
velocities towards the second peak during passive diastolic ventricular filling (D-
wave) [56] (Figure 2/3). The atrial contraction occurs in late diastole and results in 
complete filling of the ventricles, promoting a slight increase in ventricular pressure 
[57]. During the isovolumetric contraction phase of the cardiac cycle, ventricular 
pressure rises steeply with no change in ventricular volume as both the 
atrioventricular and semilunar valves are closed [57]. The fall in venous forward 
velocities produces the second trough, designated the a-wave [56] (Figure 1,2).  
Although the correlation between the DV waveform and the phases of the cardiac 
cycle can be established temporally, there is no experimental evidence for a direct 
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correlation between DV waveform and fetal heart function. Nevertheless, the 
continuity of venous forward flow fluctuates with the capacity of the heart to 
accommodate venous return, which depends on venous volume (preload), cardiac 
function (relaxation, compliance and contractility) and downstream arterial blood-
flow resistance (afterload) [58]. In other words, DV blood velocity reflects the 
portocaval pressure gradient that drives this flow in addition to the portal liver 
perfusion, as assumed previously [53,59]. However, this gradient must be modulated 
by adequate cardiac compliance, which varies according to the gestational age and in 
some fetal pathological conditions. Given that an umbilicocaval (portocaval) pressure 
gradient is the driving pressure for perfusing the liver and for causing the umbilical 
blood to reach the foramen ovale, it was assumed, in the construction of recent 
longitudinal reference ranges [53], that the peak systolic velocity or velocities close to 
this reflected the optimal perfusion pressure in the individual fetus [53]. 
 
In daily clinical practice, an abnormal flow in DV is easily identified, qualitatively, by 
observing the absence or inversion of the a-wave. In these cases, the pulsatility index 
increases significantly, translating a significant increase in the pressure gradient 
towards the right atrium. Nevertheless, it is important to keep in mind that, during 
atrial systole, the venous blood column is in continuity with the right atrium, but this 
atrium is in continuity with the left atrium and right ventricle. For this reason, the 
identification of an abnormal DV waveform requires a careful examination of the fetal 
cardiovascular system, including the placental circulation, because multiple 
mechanisms of disease can coexist. The evaluation should be done in a systematic 
way and should be morphological and functional in order to rule out pathological 
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conditions such as increased cardiac preload, abnormal cardiac structure and function, 
and increased cardiac afterload. 
 
Ductus venosus Doppler to screening of cardiac defects 
Congenital heart defects are the most commonly occurring congenital malformations 
that cause significant mortality and morbidity. For this reason, the interest in the early 
detection of this set of pathologies is a cause of concern for all those dedicated to 
prenatal diagnosis. In particular, visualization of the fetal heart with adequate 
echographic resolution is only possible from the end of the first trimester, and 
therefore, the identification of risk markers for the occurrence of congenital heart 
defects deserves the full commitment of the sonographers. Growing evidence suggests 
that assessment of DV flow improves the performance of nuchal translucency (NT) 
screening for cardiac defects.  
 
With the objective to evaluate in a meta-analysis of the screening performance of 
abnormal DV Doppler waveforms for detection of congenital heart disease (CHD) in 
chromosomally normal fetuses, a group of authors analyzed seven studies regardless 
of the NT status, nine studies with increased NT and seven studies with normal NT 
[60]. In populations including participants regardless of NT status, the summary 
sensitivity and specificity of DV for detecting CHD were 50 and 93%, respectively 
[60]. In participants with increased NT, the summary sensitivity and specificity were 
83 and 80%, and in those with normal NT, the summary sensitivity and specificity 
were 19 and 96%, respectively [60]. The findings of this meta-analysis on 
chromosomally normal fetuses demonstrate that the DV waveform examination has 
moderate sensitivity for detecting CHD [60]. However, the authors concluded that DV 
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assessment for the detection of CHD in chromosomally normal fetuses can be 
considered in evaluating the potential use and limitations of this screening test 
(Papatheodorou et al., 2011). These results are consistent with more recent evidence 
suggesting that in chromosomally normal fetuses, the addition of an abnormal DV a-
wave to increased NT does not improve the screening performance of NT in the 
detection of major hearts defects in the first trimester [61].  
 
In conclusion, in fetuses with normal NT, the sensitivity of this marker is not strong 
enough to be used as a screening test for CHD [62]. Additionally, because there are 
some small differences in the DV flow of T21 fetuses with and without CHD, DV 
flow is not clinically useful in this group of patients [63]. Further investigations are 
needed to enhance the clinical utility of the DV in association with other markers of 
CHD in high-risk pregnancies [64,65]. 
 
Ductus venosus Doppler contribution to screen for chromosomal defects 
NT screening combined with maternal age at early mid-trimester can identify 
approximately 75% of chromosomal abnormalities, with a false-positive rate of 5% [67]. 
To improve the test performance, Doppler parameters have been included in the screening of 
fetal chromosomal abnormalities. In the first trimester, a reversed a-wave is associated 
with an increased risk for chromosomal abnormalities [68] and fetal death [69] in 
singleton and twin pregnancies [70]. However, in approximately 80% of cases with a 
reversed a-wave, the pregnancy outcome is normal [69]. Combining the DV-PIV and 
NT, overall sensitivity decreased to 55%, but specificity reached 99.3%, with a negative 
predictive value of 99.3% [71]. Because changes in the DV-PIV can be found in fetuses 
with chromosomal abnormalities, with or without cardiac defects, and in those with certain 
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cardiac abnormalities with normal karyotypes, the DV-PIV should not be used as a first-line 
screening test at 10–16 weeks of gestation [71]. Although the DV-PIV does not increase 
the number of cases detected by NT, it can be useful as a second-line test in screen-
positive cases with NT in order to increase the specificity, reducing the need for invasive 
testing [8,71]. Additionally, because DV blood flow pattern is correlated with the 
nuchal translucency measurement, it cannot be used as an independent variable to 
reduce the indication for fetal karyotyping [72]. 
 
Ductus venosus Doppler in the management of intrauterine growth restriction 
Decreased, absent, or reversed flow in the a-wave of the DV may represent 
myocardial impairment and increased ventricular end-diastolic pressure resulting from 
an increase in right ventricular afterload. This abnormal DV waveform has been 
documented in fetuses with intrauterine growth restriction (IUGR) and linked to an 
increased neonatal acidemia and perinatal mortality [66]. 
 
Recently, in a sheep model of increased placental vascular resistance, a group of 
authors investigated whether hypoxemia without acidemia affects the DV blood 
velocity waveform pattern in sheep fetuses with an intact placenta and whether 
worsening acidemia and impending fetal death are related to changes in DV 
velocimetry in fetuses with increased placental vascular resistance [73]. The principal 
conclusion of this important experimental study was that fetal hypoxemia increases 
the pulsatility of the DV blood velocity waveform pattern [73]. However, 
in fetuses with elevated placental vascular resistance, DV pulsatility does not increase 
further in the presence of severe and worsening fetal acidemia and 
impending fetal death [73]. The authors state that fetal hypoxemia can increase 
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pulsatility in the DV blood velocity waveform pattern [73]. However, it appears that it 
cannot recognize those ovine fetuses that will become acidemic and even die within a 
short time period [73], suggesting that the development of an abnormal DV blood 
flow pattern requires additional pathophysiological events that lead to increased 
ventricular end-diastolic and systemic venous pressures [73]. In human fetuses, the 
duration of absent or reversed flow during atrial systole in the DV is a strong 
predictor of stillbirth that is independent of gestational age [74].  
 
Although a progressive predictable sequence of placental and fetal Doppler changes 
has been described as an adaptive mechanism to a suboptimal intrauterine 
environment in pregnancies affected by IUGR, the optimal surveillance pattern and 
timing of delivery remain the focus of much debate and research, with no 
internationally accepted approach to management [75]. With the objective to assess 
whether changes in the fetal DV Doppler waveform could be used as indications for 
delivery instead of cardiotocography (CTG), an extensive randomized study 
(including women with singleton fetuses at 26-32 weeks of gestation who had very 
preterm fetal growth restriction) found that when the timing of delivery was based on 
the study protocol using late changes in the DV waveform, the results exhibited an 
improvement in the developmental outcomes at 2 years of age [76,77]. Although 
assuming that the optimal management of early IUGR fetuses should integrate 
clinical, Doppler, and CTG parameters, the authors caution that severe anomalies in 
the DV, when they precede CTG abnormalities, are an indication for undertaking 
delivery [77]. 
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Ductus venosus Doppler contribution to screening of monochorionic twin 
complications 
Ultrasonography is central to the proper diagnosis of the type of twinning (Smith et 
al., 2018). Monochorionic twin pregnancies are at increased risk for adverse outcomes 
compared to dichorionic twin pregnancies and singletons, including twin-
twin transfusion syndrome (TTTS), twin anemia-polycythemia sequence, single 
intrauterine fetal demise and its consequences on the co-twin, and selective 
intrauterine growth restriction [78]. In particular, TTTS is associated with significant 
mortality and morbidity [79].  
 
Several studies have assessed the role of first- and early second-trimester markers in 
the prediction of TTTS in monochorionic twin pregnancies [80] because DV flow 
profiles and the timing of waveform events are already altered in preTTTS and in the 
early-stage disease [81]. As a corollary of an extensive meta-analysis that included 
approximately 2000 pregnancies, of which 323 developed TTTS, an increased risk of 
TTTS was associated with intertwin NT discrepancy (positive likelihood ratio (LR+), 
1.92 (95% CI, 1.25-2.96); a negative likelihood ratio (LR-), 0.65 (95% CI, 0.50-
0.84)); NT > 95th percentile (LR+, 2.63 (95% CI, 1.51-4.58); LR-, 0.85 (95% CI, 0.75-
0.96)); CRL discrepancy > 10% (LR+, 1.80 (95% CI, 1.05-3.07); LR-, 0.92 (95% CI, 
0.81-1.05)); and abnormal DV flow (LR+, 4.77 (95% CI, 1.33-17.04; LR-, 0.49 (95% 
CI, 0.17-1.41)) [80]. The highest sensitivities were observed for intertwin NT 
discrepancy >10% (52.8% (95% CI, 43.8-61.7%)) and abnormal DV flow (50.0% 
(95% CI, 33.4-66.6%)) [80]. Additionally, unbalanced blood volume in TTTS led to 
alterations in the time intervals of DV, suggesting that the assessment of DV Doppler 
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velocimetry will provide detailed information on fetal cardiac function before and 
after laser therapy [82]. 
 
Agenesis of the ductus venosus 
Congenital absence of the DV (ADV) is a rare vascular anomaly with a controversial 
prevalence. Prognosis largely depends on other fetal cardiac and extra-cardiac 
anomalies, chromosomopathies, the presence of effusions/hydrops fetalis and the 
pattern of umbilical venous drainage associated.  
 
There are three main patterns of drainage. If the umbilical vein bypasses the liver, it 
leads to an increased and unregulated flow into the right atrium (46%), putting this 
fetus at risk of developing cardiomegaly; this can result in high-output cardiac failure 
and hydrops. The umbilical vein can also bypass the liver and connect to the inferior 
vena cava by one iliac or renal vein (26%), causing hyperperfusion of the liver 
sinusoids and portal hypertension and hydrops. Lastly, the umbilical vein may 
connect to the portal circulation without giving rise to the DV (21%) [83,84]. 
Therefore, when ADV is detected, a more detailed fetal examination and the detection 
of other anomalies is often necessary.  
 
The exact etiology of ADV is unclear, and it may result from primary agenesis and/or 
functional or structural closure. Usually, ADV can be detected during the early scan 
of the first trimester evaluation [85], but in some cases, the ultrasound scan is reported 
as normal in early pregnancy; there can be a missed diagnosis, but another 
explanation is the formation of a secondary closure due to an unknown gradual 
condition [86]. ADV can appear associated with varying comorbidities, some of 
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which are incompatible with life: cardiomegaly, chromosomopathies, altered fetal 
growth and hepatic calcifications [87]. It was reported [84] that the overall survival 
rate was 60% and only 50% when the ADV was associated with effusions/hydrops. 
However, if there was no evidence of hydrops and cardiac overload associated with 
the ADV, the survival rate was 100%, regardless of the type of ADV [84]. In fact, 
many studies report a good outcome when there is no further pathological finding, as 
chromosomopathy or hydrops [84,85,88]. Fetuses with ADV and restrictive 
alternative umbilical venous pathways may have a more benign clinical course 
because the “small shunt” is unlikely to induce cardiac failure [88]. Not only the 
caliber of the shunt but also the NT thickness seems to be important in the evaluation 
of the prognosis, unless ADV appears isolated [85,88].  
Postnatally, cessation of umbilical venous flow occurs, and the short-term impact 
does not appear to be significant [84], with a regression of the anomaly [88]. 
However, ADV may lead to significant long-term complications if associated with 
particular fetal anomalies, such as portal vein agenesis with extrahepatic umbilical 
vein drainage or congenital absence of the portal venous system. Although ADV with 
intrahepatic drainage is associated with better chances of survival, infants with 
congenital absence of the portal venous system, complicated with intrahepatic 
drainage, have a potentially serious condition [86].  
 
Fetal echocardiography, with access to detailed anatomy, and fetal karyotyping are 
recommended actions when ADV is noticed (Thomas et al., 2012). The ultrasound 
plays an important role not only in detecting abnormalities that can help dictate the 
prognosis but also allowing parental counseling.  
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Patent ductus venosus  
Patent DV (PDV) is a rare congenital condition where the DV persists as a 
portosystemic shunt connecting the portal system and inferior vena cava [89-91]. 
 
A DV flow effect in neonatal liver and its persistence after birth remain an unclear 
subject [90-92]. Few cases have been described so far, and diagnoses occurred not 
only in early childhood but also in adulthood or even on autopsy studies [93-96]. The 
majority appear sporadic, but a recessive genetic heritage has been hypothesized since 
the description of PDV in three brothers [89]. 
 
DV blood flow influences important liver functions in early neonates, such as 
ammonia detoxification, coagulation and serum bile acid concentration [97]. When 
this portosystemic communication persists, hepatic atrophy and hepatic failure will 
develop, and biochemical markers include hypergalactosemia, hyperbilirubinemia, 
hyperammonemia, an increased coagulation time and an augmented serum bile acid 
concentration. Thereafter, presentation of PDV includes systemic manifestations, 
representing hepatic, pulmonary and cardiac dysfunction [97-99]. Manifestations 
reported include cholestatic jaundice [93-100], hepatic encephalopathy [91,94,95,99], 
massive gastrointestinal bleeding [98]; acute liver failure [99,101]; respiratory distress 
[102] and pulmonary arteriovenous fistulae [103,104], and tumor-like hepatic lesions 
[92,105]. A child with a single ventricle, who presented with spontaneous 
microbubbles on echocardiography, was found to have a PDV [106]. Other peculiar 
associations have been reported. Yamaguchi et al. presented a girl with Down 
syndrome who was diagnosed with PDV after neonatal cholestasis and a transient 
abnormal myeloproliferative disorder [100]. Sagiv-Friedgut et al. questioned a 
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genetically linked association of PDV and immunoglobulin E syndrome after their 
description of these conditions in a pair of siblings [107]. An association between 
PDV and autoimmune disorders was noted by Yashimoto et al. [102]. Acute liver 
failure has been associated not only with PDV but also with Enterovirus infection and 
neonatal hemochromatosis [99,101]. One case of Budd-Chiari syndrome has been 
associated with PDV and confirmed only in autopsy [96].  
 
Given these pleiotropic presentations, diagnosis may be challenging. Usually, 
biochemical alterations suggest a hepatic disorder, and a liver ultrasound or 
abdominal computed tomography (with or without angiographic study) is performed. 
This may reveal or at least raise the suspicion of a portosystemic shunt 
[91,94,95,97,99,102,103,105,106]. Magnetic resonance angiography has also been 
suggested as an important diagnostic tool, specifically for infants [108].  
 
Most cases improve substantially with anomalous shunt closure by surgical ligation 
(via laparotomy or laparoscopy) or embolization using a vascular plug through 
interventional radiology [90,91,93-95,98,99,101-104]. 
 
Conclusion  
In conclusion, the DV acts as a bypass of the liver microcirculation and plays a 
critical role in the fetal circulation. The DV allows oxygenated and nutrient-rich 
venous blood to flow from the placenta to the myocardium and brain. Increased 
impedance to flow in the fetal DV is associated with fetal aneuploidies, cardiac 
defects and other adverse pregnancy outcomes. Further research is necessary to 
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determine the importance of the DV Doppler assessment in improving perinatal 
outcomes. 
 
List of Abbreviations 
ADV, congenital absence of the ductus venosus 
CHD, congenital heart disease 
CTG, cardiotocography 
DV, ductus venosus 
DV-PIV, ductus venosus pulsatility index 
IUGR, intrauterine growth restriction 
NT, nuchal translucency 
PDV, patent ductus venosus 
T21, Trisomy 21 
TGF-β, transforming growth factor β 
TTTS, twin-twin transfusion syndrome 
UV, umbilical vein 
VEGF, of vascular endothelial growth factor 
VS, vasculogenesis 
 
Ethics Committee Approval 
N/A 
 
Peer-review  
Externally peer-reviewed. 
  
25 
 
Author Contributions 
Concept – M.B., L.G.-M.; Design – M.B., L.G.-M.; L.M.; Supervision – L.G.-M.; 
Literature Review – M.B., L.G.-M.; Writer – M.B., L.G.-M.; L.M.; Critical Review- 
L.G.-M., M.B. 
 
Conflicts of Interest 
We have no conflicts of interest in this review. 
 
Acknowledgements 
The staff of the Department of Obstetrics of Centro Hospitalar do Porto is 
acknowledged. 
 
Financial Disclosure 
The authors declared that this study received no financial support. 
 
References 
1. Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR. Ultrasonographic velocimetry of 
the fetal ductus venosus. Lancet. 1991 Dec 7;338(8780):1412-4.  
2. Kiserud T. The ductus venosus. Semin Perinatol. 2001 Feb;25(1):11-20. 
3. Tchirikov M, Schröder HJ, Hecher K. Ductus venosus shunting in the fetal venous 
circulation: regulatory mechanisms, diagnostic methods and medical importance. 
Ultrasound Obstet Gynecol. 2006 Apr;27(4):452-61.  
  
26 
4. Kiserud T, Acharya G. The fetal circulation. Prenat Diagn. 2004 Dec 
30;24(13):1049-59.  
5. Tchirikov M, Schlabritz-Loutsevitch NE, Hubbard GB, Nathanielsz PW, Beindorff 
N, Schroder HJ. Ductus venosus shunting in marmoset and baboon fetuses. 
Ultrasound Obstet Gynecol 2005; 26: 252 – 257 
6. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in 
chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 
weeks. Ultrasound Obstet Gynecol. 1999 Nov;14(5):307-10.  
7. Matias A, Montenegro N, Areias JC, Leite LP. Haemodynamic evaluation of the 
first trimester fetus with special emphasis on venous return. Hum Reprod Update. 
2000 Mar-Apr;6(2):177-89.  
8. Matias A, Montenegro N. Ductus venosus blood flow in chromosomally abnormal 
fetuses at 11 to 14 weeks of gestation. Semin Perinatol. 2001 Feb;25(1):32-7.  
9. Matias A, Montenegro N, Loureiro T, et al. Screening for twin-twin transfusion 
syndrome at 11-14 weeks of pregnancy: the key role of ductus venosus blood flow 
assessment. Ultrasound Obstet Gynecol. 2010 Feb;35(2):142-8.  
10. Byrd N, and Grabel L: Hedgehog signaling in murine vasculogenesis and 
angiogenesis. Trends Cardiovasc Med 2004; 14: pp. 308-313 
11. Eric D. Endean, Bruce E. Maley. Rutherford's Vascular Surgery / [edited by] Jack 
L. Cronenwett, K. Wayne Johnston, by Saunders, an imprint of Elsevier Inc., Eighth 
Edition, 2014, Chapter 2, 15-33. 
12. Zhan W, et al: Regulation of Hex gene expression and initial stages of avian 
hepatogenesis by Bmp and Fgf signaling. Dev Biol 2004; 268: pp. 312-326 
  
27 
13. Red-Horse K, Crawford Y, Shojaei F, Ferrara N. Endothelium microenvironment 
interactions in the developing embryo and in the adult. Dev Cell. 2007 Feb;12(2):181-
94. 
14. Adams RH, Alitalo K. Molecular regulation of angiogenesis and 
lymphangiogenesis. Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78.  
15. Tchirikov M, Rybakowski C, Huneke B, Schr oder HJ. Blood flow through the 
ductus venosus in singleton and multifetal pregnancies and in fetuses with I 
ntrauterine growth retardation. Am J Obstet Gynecol 1998; 178: 943 – 949 
16. Bellotti M, Pennati G, De Gasperi C, Bozzo M, Battaglia FC, Ferrazzi E. 
Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus 
blood flow in growth-restricted human fetuses. Am J Obstet Gynecol 2004; 190: 1347 
– 1358 
17. Power GG, Longo LD. Fetal circulation times and their implications for tissue 
oxygenation. Gynecol Invest 1975; 6: 342 – 355. 
18. Edelstone DI, Rudolph AM, Heymann MA. Effects of hypoxemia and decreasing 
umbilical flow liver and ductus venosus blood flows in fetal lambs. Am J Physiol 
1980; 238: H656 – 663. 
19. Reuss ML, Rudolph AM. Distribution and recirculation of umbilical and systemic 
venous blood flow in fetal lambs during hypoxia. JDevPhysiol 1980; 2: 71 – 84. 
20. Itskovitz J, Goetzman BW, Rudolph AM. Effects of hemorrhage on umbilical 
venous return and oxygen delivery in fetal lambs. Am J Physiol 1982; 242: H543 – 
548. 
21. Itskovitz J, LaGamma EF, Rudolph AM. Effects of cord compression on fetal 
blood flow distribution and O2 delivery. Am J Physiol 1987; 252: H100 – 109. 
  
28 
22. Paulick RP, Meyers RL, Rudolph CD, Rudolph AM. Venous responses to 
hypoxemia in the fetal lamb. JDevPhysiol 1990; 14: 81 – 88. 
23. Paulick RP, Meyers RL, Rudolph CD, Rudolph AM. Umbilical and hepatic 
venous responses to circulating vasoconstrictive hormones in fetal lamb. Am J 
Physiol 1991; 260: H1205 – 1213. 
24. Jensen A, Roman C, Rudolph AM. Effects of reducing uterine blood flow on fetal 
blood flow distribution and oxygen delivery. JDevPhysiol 1991; 15: 309 – 323. 
25. Kiserud T, Ozaki T, Nishina H, Rodeck C, Hanson MA. Effect of NO, 
phenylephrine, and hypoxemia on ductus venosus diameter in fetal sheep. Am J 
Physiol 2000a; 279: H1166 – 1171. 
26. Tchirikov M, Hecher K, Deprest J, Zikulnig L, Devlieger R, Schr̈oder HJ. Doppler 
ultrasound measurements in the central circulation of anesthetized fetal sheep during 
obstruction of umbilical – placental blood flow. Ultrasound Obstet Gynecol 2001; 18: 
656 – 661. 
27. Behrman RE, Lees MH, Peterson EN, De Lannoy CW, Seeds AE. Distribution of 
the circulation in the normal and asphyxiated fetal primate. Am J Obstet Gynecol 
1970; 108: 956 – 969 
28. Paton JB, Fisher DE, DeLannoy CW, Behrman RE. Umbilical blood flow, cardiac 
output, and organ blood flow in the immature baboon fetus. Am J Obstet Gynecol 
1973; 117: 560 – 566. 
29. Rudolph AM, Heymann MA, Teramo KAW, Barrett CT, Raiha NCR. Studies on 
the circulations of the previable human fetus. Pediatr Res 1971; 5: 452 – 465 
30. Kiserud T, Rasmussen S, Skulstad S. Blood flow and the degree of shunting 
through the ductus venosus in the human fetus. Am J Obstet Gynecol 2000a; 182: 147 
– 153. 
  
29 
31. Bellotti M, Pennati G, De Gasper iC, Battaglia FC, Ferrazzi E. Role of ductus 
venosus in distribution of umbilical blood flow in human fetuses during second half 
of pregnancy. Am J Physiol Heart Circ Physiol 2000; 279: H1256 – 1263. 
32. Haugen G, Kiserud T, Godfrey K, Crozier S, Hanson M. Portal and umbilical 
venous blood supply to the liver in the human fetus near term. Ultrasound Obstet 
Gynecol 2004; 24: 599 – 605 
33. Tchirikov M, Eisermann K, Rybakowski C, Schr̈oder HJ. Doppler ultrasound 
evaluation of ductus venosus blood flow during acute hypoxemia in fetal lambs. 
Ultrasound Obstet Gynecol 1998; 11: 426 – 431. 
34. Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH. Learning curve for 
Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks' gestation. 
Ultrasound Obstet Gynecol. 2008 May;31(5):503-6.  
35. Gürses C. How to get ductus venosus flow velocity waveforms between 11 and 14 
weeks: Candle Flame and Falling Drop Signs. Med Ultrason. 2016 Dec 5;18(4):528-
529. 
36. Wiechec M, Nocun A, Matyszkiewicz A, Wiercinska E, Latała E. First trimester 
severe ductus venosus flow abnormalities in isolation or combination with other 
markers of aneuploidy and fetal anomalies. J Perinat Med. 2016 Mar;44(2):201-9.  
37. Kagan KO, Wright D, Nicolaides KH. First-trimester contingent screening for 
trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and  
maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol. 2015 Jan;45(1):42-
7.  
38. Togrul C, Ozaksit GM, Seckin KD, Baser E, Karsli MF, Gungor T. Is there a role 
for fetal ductus venosus and hepatic artery Doppler in screening for fetal aneuploidy 
in the first trimester? J Matern Fetal Neonatal Med. 2015;28(14):1716-9.  
  
30 
39. Florjański J, Fuchs T, Zimmer M, Homola W, Pomorski M, Blok D. The role of 
ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during  
the first trimester of pregnancy. Adv Clin Exp Med. 2013 May-Jun;22(3):395-401.  
40. Sabria J, Comas C, Barceló-Vidal C, et al. Cumulative sum plots and retrospective 
parameters in first-trimester ductus venosus quality assurance. Prenat Diagn. 2013 
Apr;33(4):384-90.  
41. Karakoç G, Yavuz A, Eriş Yalçın S, Akkurt MÖ, Danışman N. The significance 
of  reverse flow in ductus venosus between sixteen and twenty weeks' gestation. Turk  
J Obstet Gynecol. 2017 Mar;14(1):23 27. 
42. Suksai M, Suwanrath C, Kor-Anantakul O, Geater A. Time Interval 
Measurements of the Ductus Venosus During the Early Second Trimester of 
Pregnancy: Reference Ranges and Clinical Application. J Ultrasound Med. 2018 
Mar;37(3):745-753.  
43. Pokharel P, Ansari MA. Fetal Ductus Venosus Pulsatility Index and Diameter 
during Second and Third Trimester of Gestation. JNMA J Nepal Med Assoc. 2017 
Jan-Mar;56(205):124-131.  
44. İlhan G, İyibozkurt AC, Kalelioğlu Hİ, et al. Effects of fetal cardiac anomalies on 
ductus venosus and aortic isthmus doppler profiles. Arch Gynecol Obstet. 2016 
Feb;293(2):345-50.  
45. Martins WP, Kiserud T. How to record ductus venosus blood velocity in the 
second half of pregnancy. Ultrasound Obstet Gynecol. 2013 Aug;42(2):245-6.  
46. Demirturk F, Caliskan AC, Aytan H, Sahin S. A preliminary retrospective study 
about the relationship between ductus venosus Doppler indices, nuchal translucency 
(NT) and biochemical markers in the first and second trimester screening tests. 
Gynecol Endocrinol. 2012 May;28(5):378-81.  
  
31 
47. Tongprasert F, Srisupundit K, Luewan S, Wanapirak C, Tongsong T. Normal 
reference ranges of ductus venosus Doppler indices in the period from 14 to 40 weeks' 
gestation. Gynecol Obstet Invest. 2012;73(1):32-7. 
48. Stressig R, Kozlowski P, Froehlich S, et al. Assessment of the ductus venosus, 
tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21. 
Ultrasound Obstet Gynecol. 2011 Apr;37(4):444-9.  
49. Hung JH, Fu CY, Lu JH, Hung CY. Ductus venosus blood flow resistance and 
congenital heart defects in the second trimester. J Clin Ultrasound. 2008 
Feb;36(2):72-8. 
50. Hecher K, Campbell S, Snijders R, Nicolaides K. Reference ranges for fetal 
venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol. 1994 
Sep 1;4(5):381-390.  
51. Fetal Medicine Foundation. Available at https://fetalmedicine.org/fmf-
certification/certificates-of-competence/ductus-venosus-flow. Accessed October 30, 
2017. 
52. Teixeira LS, Leite J, Viegas MJ, et al. Ductus venosus Doppler velocimetry in the 
first trimester: a new finding. Ultrasound Obstet Gynecol. 2008 Mar;31(3):261-5.  
53. Kessler J, Rasmussen S, Hanson M, Kiserud T. Longitudinal reference ranges for 
ductus venosus flow velocities and waveform indices. Ultrasound Obstet Gynecol. 
2006 Dec;28(7):890-8. 
54. Prefumo F, Risso D, Venturini PL, De Biasio P. Reference values for ductos 
venosus Doppler flow measurements at 10-14 weeks of gestation. Ultrasound Obstet 
Gynecol. 2002 Jul;20(1):42-6.  
  
32 
55. Bahlmann F, Wellek S, Reinhardt I, Merz E, Steiner E, Welter C. Reference 
values of ductus venosus flow velocities and calculated waveform indices. Prenat  
Diagn. 2000 Aug;20(8):623-34.  
56. Baschat AA, Turan OM, Turan S. Ductus venosus blood-flow patterns: more than 
meets the eye? Ultrasound Obstet Gynecol. 2012 May;39(5):598-9. 
57. Abuhamad A, Chaoui R. Foetal cardiac function. In: Abuhamad A, Chaoui R. A 
pratical guide to foetal echocardiography. 3
rd
 ed. Wolters Kluwer 2016; pp.178-186.    
58. Sanapo L, Turan OM, Turan S, Ton J, Atlas M, Baschat AA. Correlation analysis 
of ductus venosus velocity indices and fetal cardiac function. Ultrasound Obstet 
Gynecol. 2014 May;43(5):515-9. 
59. Kiserud T, Hellevik LR, Eik-Nes SH, Angelsen BA, Blaas HG. Estimation of the 
pressure gradient across the fetal ductus venosus based on Doppler velocimetry. 
Ultrasound Med Biol 1994; 20: 225 – 232. 
60. Papatheodorou SI, Evangelou E, Makrydimas G, Ioannidis JP. First-trimester 
ductus venosus screening for cardiac defects: a meta-analysis. BJOG. 2011 
Nov;118(12):1438-45. 
61. Karadzov-Orlic N, Egic A, Filimonovic D, Damnjanovic-Pazin B, Milovanovic Z, 
Lukic R, Mandic V, Joksic I, Vukomanovic V, Kosutic J, Djuricic S, Mikovic Z. 
Screening performances of abnormal first-trimester ductus venosus blood flow and  
increased nuchal translucency thickness in detection of major heart defects. Prenat 
Diagn. 2015 Dec;35(13):1308-15. 
62. Prats P, Ferrer Q, Comas C, Rodríguez I. Is the addition of the ductus venosus 
useful when screening for aneuploidy and congenital heart disease in fetuses with 
normal nuchal translucency? Fetal Diagn Ther. 2012;32(1 2):138-43 
  
33 
63. Wagner P, Sonek J, Eberle K, et al. First trimester screening for major cardiac 
defects based on the ductus venosus flow in fetuses with trisomy 21. Prenat Diagn. 
2018 Apr 16.  
64. Alfirevic Z, Stampalija T, Dowswell T. Fetal and umbilical Doppler ultrasound in 
high-risk pregnancies. Cochrane Database Syst Rev. 2017 Jun 13;6:CD007529.  
65. Cheema R, Bayoumi MZ, Gudmundsson S. Multivascular Doppler surveillance in 
high risk pregnancies. J Matern Fetal Neonatal Med. 2012 Jul;25(7):970-4.  
66. Baschat AA. Ductus venosus Doppler for fetal surveillance in high risk 
pregnancies. Clin Obstet Gynecol. 2010 Dec;53(4):858-68.  
67. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers 
of chromosomal abnormalities. Am J Obstet Gynecol. 2004 Jul;191(1):45-67.  
68. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for 
chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. 
Ultrasound Obstet Gynecol. 1998 Dec;12(6):380-4.  
69. Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH. Screening for 
adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of 
gestation. Obstet Gynecol. 2008 Sep;112(3):598-605.  
70. Maiz N, Nicolaides KH. Ductus venosus in the first trimester: contribution to 
screening of chromosomal, cardiac defects and monochorionic twin complications. 
Fetal Diagn Ther. 2010;28(2):65-71.  
71. Antolín E, Comas C, Torrents M, et al. The role of ductus venosus blood flow 
assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. 
Ultrasound Obstet Gynecol. 2001 Apr;17(4):295-300.  
72. Bilardo CM, Müller MA, Zikulnig L, Schipper M, Hecher K. Ductus venosus 
studies in fetuses at high risk for chromosomal or heart  bnormalities: relationship 
  
34 
with nuchal translucency measurement and fetal outcome. Ultrasound Obstet 
Gynecol. 2001 Apr;17(4):288-94.  
73. Mäkikallio K, Acharya G, Erkinaro T, et al. Ductus venosus velocimetry in acute 
fetal acidemia and impending fetal death in a sheep model of increased placental 
vascular resistance. Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1229-34. 
74. Turan OM, Turan S, Berg C, Gembruch U, Nicolaides KH, Harman CR, Baschat 
AA. Duration of persistent abnormal ductus venosus flow and its impact on perinatal 
outcome in fetal growth restriction. Ultrasound Obstet Gynecol. 2011 Sep;38(3):295-
302. 
75. Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O'Donoghue 
K, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD. Predictable 
progressive Doppler deterioration in IUGR: does it really exist? Am J Obstet 
Gynecol. 2013 Dec;209(6):539.e1-7. 
76. Lees CC, Marlow N, van Wassenaer-Leemhuis A, et al; TRUFFLE study group. 2 
year neurodevelopmental and intermediate perinatal outcomes in infants with very 
preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet. 2015 May 
30;385(9983):2162-72.  
77. Frusca T, Todros T, Lees C, Bilardo CM; TRUFFLE Investigators. Outcome in 
early-onset fetal growth restriction is best combining computerized foetal heart rate 
analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal 
Flow in Europe. Am J Obstet Gynecol. 2018 Feb;218(2S):S783-S789. 
78. Djaafri F, Stirnemann J, Mediouni I, Colmant C, Ville Y. Twin-twin transfusion 
syndrome - What we have learned from clinical trials. Semin Fetal Neonatal Med. 
2017 Dec;22(6):367-375. 
  
35 
79. Perry H, Duffy JMN, Umadia O, Khalil A; International Collaboration to 
Harmonise Outcomes for Twin-Twin Transfusion Syndrome (CHOOSE). Outcome 
reporting across randomised trials and observational studies evaluating treatments for 
Twin-Twin Transfusion Syndrome: a systematic review. Ultrasound Obstet Gynecol. 
2018 Apr 1. 
80. Stagnati V, Zanardini C, Fichera A, Pagani G, Quintero RA, Bellocco R, Prefumo 
F. Early prediction of twin-to-twin transfusion syndrome: systematic review and 
meta-analysis. Ultrasound Obstet Gynecol. 2017 May;49(5):573-582.  
81. Wohlmuth C, Boudreaux D, Moise KJ Jr, Johnson A, Papanna R, Bebbington M, 
Gardiner HM. Cardiac pathophysiology in twin-twin transfusion syndrome: new 
insights into its evolution. Ultrasound Obstet Gynecol. 2018 Mar;51(3):341 348. 
82. Tachibana D, Glosemeyer P, Diehl W, Nakagawa K, Wada N, Kurihara Y, Fukui 
M, Koyama M, Hecher K. Time-interval analysis of ductus venosus flow velocity 
waveforms in twin-to-twin transfusion syndrome treated with laser surgery. 
Ultrasound Obstet Gynecol. 2015 May;45(5):544-50. 
83. Maruotti GM, Saccone G, Ciardulli A, Mazzarelli LL, Berghella V, Martinelli P. 
Absent ductus venosus: case series from two tertiary centres. J Matern Foetal 
Neonatal Med. 2017 Jul 12:1-6.  
84. Thomas JT, Petersen S, Cincotta R, Lee-Tannock A, Gardener G. Absent ductus 
venosus--outcomes and implications from a tertiary centre. Prenat Diagn. 2012 
Jul;32(7):686-91.  
85. Iliescu DG, Cara ML, Tudorache S, et al. Agenesis of ductus venosus in 
sequential first and second trimester screening. Prenat Diagn. 2014 Nov;34(11):1099-
105.  
  
36 
86. Berg C, Kamil D, Geipel A, et al. Absence of ductus venosus-importance of 
umbilical venous drainage site. Ultrasound Obstet Gynecol. 2006 Sep;28(3):275-81.  
87. Garcia-Delgado R, Garcia-Rodriguez R, Romero Requejo A, et al. Echographic 
features and perinatal outcomes in fetuses with congenital absence of ductus venosus. 
Acta Obstet Gynecol Scand. 2017 Oct;96(10):1205-1213.  
88. Hofmann SR, Heilmann A, Häusler HJ, Kamin G, Nitzsche KI. Agenesis of the 
ductus venosus-A case with favorable outcome after early signs of cardiac failure. J 
Clin Ultrasound. 2013 Mar-Apr;41(3):187-90.  
89. Jacob S, Farr G, De Vun D, Takiff H, Mason A. Hepatic manifestations of 
familial patent ductus venosus in adults. Gut. 1999 Sep;45(3):442-5.  
90. Kamimatsuse A, Onitake Y, Kamei N, et al. Surgical intervention for patent 
ductus venosus. Pediatr Surg Int. 2010 Oct;26(10):1025-30.  
91. Llanos D, Armijo J, Bodas A, Vaquero E, de la Pedraja I, Arrazola J. Transjugular 
closure of a patent ductus venosus in a symptomatic 14-year-old boy using a vascular 
plug. J Pediatr. 2014 Feb;164(2):426.e1-2.  
92. Schierz IA, La Placa S, Giuffrè M, Montalbano G, Lenzo M, Corsello G. 
Transient hepatic nodular lesions associated with patent ductus venosus in preterm 
infants. Am J Perinatol. 2011 Mar;28(3):177-80.  
93. Chacko A, Kock C, Joshi JA, Mitchell L, Ahmad S. Patent ductus venosus 
presenting with cholestatic jaundice in an infant with successful trans-catheter  
closure using a vascular plug device. Indian J Radiol Imaging. 2016 Jul-
Sep;26(3):377-382.  
94. Saito M, Seo Y, Yano Y, et al. Successful treatment using coil embolization of a 
symptomatic intrahepatic portosystemic venous shunt developing through a patent 
ductus venosus in a noncirrhotic adult. Intern Med. 2013;52(5):555-9.  
  
37 
95. Hara Y, Sato Y, Yamamoto S, et al. Successful laparoscopic division of a patent 
ductus venosus: report of a case. Surg Today. 2013 Apr;43(4):434-8.  
96. Macchi V, Porzionato A, Tiengo C, Parenti A, De Caro R. Persistence of 
embryonic pattern of hepatocaval venous junction and patent ductus venosus in Budd-
Chiari syndrome. Clin Anat. 2006 Oct;19(7):673-7.  
97. Murayama K, Nagasaka H, Tate K, et al. Significant correlations between the flow 
volume of patent ductus venosus and early neonatal liver function: possible 
involvement of patent ductus venosus in postnatal liver function. Arch Dis Child Fetal 
Neonatal Ed. 2006 May;91(3):F175-9. Epub 2006 Jan 31.  
98. Alomari AI, Chaudry G, Fox VL, Fishman SJ, Buchmiller TL. Atypical 
manifestation of patent ductus venosus in a child: intervening against a paradoxical 
presentation. J Vasc Interv Radiol. 2009 Apr;20(4):537-42.  
99. Sharma R, Crowley J, Squires R, et al. Neonatal acute liver failure complicated by 
patent ductus venosus: diagnosis and  management. Liver Transpl. 2013 
Sep;19(9):1049-52. 
100. Yamaguchi H, Kosugiyama K, Honda S, Tadao O, Taketomi A, Iwata S. Down 
Syndrome with Patent Ductus Venosus and Hepato-Biliary-Pancreatic Abnormalities.  
Indian J Pediatr. 2016 Jan;83(1):78-80.  
101. Knisely AS. Patent ductus venosus and acute liver failure in the neonate: 
consider neonatal hemochromatosis with liver scarring. Liver Transpl. 2014 
Jan;20(1):124. 
102. Yoshimoto Y, Shimizu R, Saeki T, et al. Patent ductus venosus in children: a 
case report and review of the literature. J Pediatr Surg. 2004 Jan;39(1):E1-5.  
  
38 
103. Subramanian V, Kavassery MK, Sivasubramonian S, Sasidharan B. 
Percutaneous device closure of persistent ductus venosus presenting with hemoptysis. 
Ann Pediatr Cardiol. 2013 Jul-Dec; 6(2): 173–175.  
104. Kamata S, Kitayama Y, Usui N, et al. Patent ductus venosus with a hypoplastic 
intrahepatic portal system presenting intrapulmonary shunt: a case treated with 
banding of the ductus venosus. J Pediatr Surg. 2000 Apr;35(4):655-7.  
105. Aydinli M, Onal IK, Harmanci O, Ersoy O, Balkanci F, Bayraktar Y. A case of 
patent ductus venosus complicated with tumor-like lesions of the liver. J Natl Med 
Assoc. 2008 Jan;100(1):108-11.  
106. Toib A, Goldstein SB, Khanna G, et al. Spontaneous echocardiographic contrast 
associated with portosystemic shunt due to persistent patent ductus venosus. Congenit 
Heart Dis. 2012 May Jun;7(3):E18-21.  
107. Sagiv-Friedgut K, Witzling M, Dalal I, Vinkler C, Someh E, Levine A. 
Congenital patent ductus venosus: an association with the hyper IgE syndrome. J 
Pediatr. 2007 Feb;150(2):210 2.  
108. Scheer I, Kivelitz D, Taupitz M, et al. Patent ductus venosus: diagnosis by MR 
angiography. Pediatr Radiol. 2001 Apr;31(4):279-82.   
 
 
 
 
